ArticleAlzheimer's research & therapy2018

Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's disease.

Frederic Brosseron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.